Download PDF
Exp Clin Endocrinol Diabetes 1997; 105: 64-69
DOI: 10.1055/s-0029-1211801
© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York

New drugs and clinical trials in diabetes and hypertension

Peter Nilsson
  • Department of Community Health Sciences, University of Lund, Sweden
Further Information

Publication History

Publication Date:
14 July 2009 (online)

Also available at
 PDF Download  Permissions and Reprints

Summary

Hypertension is a well-established risk factor for cerebro-cardiovascular disease in diabetics, as well as for progressing renal disease. Several pathophysiological mechanisms link hypertension with non-insulin-dependent diabetes (NIDDM), e.g. insulin resistance. This will be discussed below as regards pathophysiology and treatment possibilities, especially with new drugs in ongoing clinical trials.

Key words

diabetes - hypertension - insulin resistance - troglitazone - clinical trials